Masaru Matsuda insider trades
Open-market stock purchases and sales by Masaru Matsuda, See Remarks at Arcutis Biotherapeutics, Inc, from SEC Form 4 filings since Feb 10, 2020.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +199%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 4, 2026 | ARQT Arcutis Biotherapeutics, Inc | Sold | $172K |
| May 4, 2026 | ARQT Arcutis Biotherapeutics, Inc | Sold | $20.9K |
| Mar 2, 2026 | ARQT Arcutis Biotherapeutics, Inc | Sold | $165K |
| Mar 2, 2026 | ARQT Arcutis Biotherapeutics, Inc | Sold | $5K |
| Mar 2, 2026 | ARQT Arcutis Biotherapeutics, Inc | Sold | $51.1K |
| Feb 27, 2026 | ARQT Arcutis Biotherapeutics, Inc | Bought (not open market) | — |
| Feb 27, 2026 | ARQT Arcutis Biotherapeutics, Inc | Bought (not open market) | — |
| Feb 27, 2026 | ARQT Arcutis Biotherapeutics, Inc | Sold | $92.9K |
| Feb 2, 2026 | ARQT Arcutis Biotherapeutics, Inc | Sold | $204K |
| Feb 2, 2026 | ARQT Arcutis Biotherapeutics, Inc | Sold | $214K |
| Feb 2, 2026 | ARQT Arcutis Biotherapeutics, Inc | Sold | $489K |
| Feb 2, 2026 | ARQT Arcutis Biotherapeutics, Inc | Sold | $121K |
| Dec 1, 2025 | ARQT Arcutis Biotherapeutics, Inc | Sold | $50.1K |
| Nov 19, 2025 | ARQT Arcutis Biotherapeutics, Inc | Sold | $27.6K |
| Nov 19, 2025 | ARQT Arcutis Biotherapeutics, Inc | Sold | $44.5K |
| Nov 3, 2025 | ARQT Arcutis Biotherapeutics, Inc | Sold | $177K |
| Nov 3, 2025 | ARQT Arcutis Biotherapeutics, Inc | Sold | $1.1K |